web analytics
May 26, 2015 / 8 Sivan, 5775
At a Glance
News & Views
Sponsored Post


Teva’s Parkinson Drug Now Marketed in Japan

Japan’s largest pharmaceutical company, Takeda, recently signed an agreement with Teva Pharmaceutical Industries to commercialize the Israeli company’s innovative treatment for Parkinson’s disease, rasagiline, in Japan.

The rasagiline tablets, which are approved in over 40 countries for the treatment of Parkinson’s disease, gained UK and EU-marketing authorization in 2005 and US FDA approval in 2006.

“It is estimated there are about 150,000-180,000 people diagnosed with Parkinson’s disease in Japan, many of whom are waiting for a new treatment option,” said Nancy Joseph-Ridge, M.D., General Manager of Takeda’s Pharmaceutical Development Division located in Osaka, Japan in a press release on April 27.

“We will continue working on the development in cooperation with Teva so that we can bring this medicine to Japanese patients as quickly as possible,” Joseph-Ridge said.

“This agreement represents Teva’s continued commitment to introducing our innovative medicines to patients in Japan,” added Teva Global R&D president and Chief Scientific Officer, Dr. Michael Hayden.

Teva and Takeda entered an agreement in December 2013 to develop glatiramer acetate for the treatment of multiple sclerosis.

Developed by Teva, rasagiline was initially discovered by two Haifa Technion professors, John Finberg and Moussa Youdim, who were instrumental in the early clinical development of the anti-Parkinson drug.

Parkinson’s disease is a degenerative disorder of the central nervous system, whose symptoms include shaking, rigidity, slowness of movement and difficultly with walking as well as dementia in advanced stages. An estimated seven to 10 million people suffer from the disease across the world according to the Parkinson’s Disease Foundation.

According to Teva’s website, rasagiline is a monoaxmine oxidase B (MAO-B) inhibitor that increases available synaptic dopamine in the brain, which might improve the motor symptoms characteristic of Parkinson’s, slowing the progression of the disease.

“Rasagiline has an established safety and efficacy profile…[it] will be an important product for Japan, where the number of available treatment options for Parkinson’s disease remains limited,” said Dr. Hayden.

About the Author: Anav Silverman is a regular contributor to Tazpit News Agency.


If you don't see your comment after publishing it, refresh the page.

Our comments section is intended for meaningful responses and debates in a civilized manner. We ask that you respect the fact that we are a religious Jewish website and avoid inappropriate language at all cost.

If you promote any foreign religions, gods or messiahs, lies about Israel, anti-Semitism, or advocate violence (except against terrorists), your permission to comment may be revoked.

2 Responses to “Teva’s Parkinson Drug Now Marketed in Japan”

  1. Judith Dowla says:

    TEVA is an excellent pharmaceutical company that offers a considerable amount of funds into research and is on the leading edge in finding the best possible treatment for various diseases and with a focus as well on receptors involving the nerves that become disturbed via a variety of causes. The goal is to do what is best to help the patient overcome and manage the disturbances that can make life very uncomfortable. Keep up the good work TEVA.

Comments are closed.

Current Top Story
EU foreign policy chief Federica Mogherini of Italy.
Media Spins Netanyahu’s Renewal of Peace Process
Latest News Stories
EU foreign policy chief Federica Mogherini of Italy.

Netanyahu pacified the EU and said he wants to resume talks on new borders, which the Palestinian Authority total rejects.

Stray bullets from Gaza terrorists’ live-fire training exercises have landed in Israeli communities near the security fence, HaKol Yehudi reported Tuesday. It said that the IDF has claimed they were “stray bullets.” Hamas terrorists reportedly are carrying out live-fire training are paving a new road less than 200 yards from the fence.

Students learning Torah at Ode Yosef Chai yeshiva in Yitzhar.

Have the Border Police learned enough Torah the past year?

Israel's President Reuven Rivlin

The Office of President Reuven Rivlin has denied reports that he will receive on Thursday a citation of honor from the left-wing New Israel Fund (NIF) on Thursday. It clarified that the Jewish-Arab Center at Givat Haviva, which is funded in part by the NIF, is awarding the President. Rivlin’s office stated: The Jewish-Arab Center […]

Woodstock was not so original, according to Israeli archaeologists.

Erdan is set to be sworn in as the new Minister of Internal Security, Strategic Affairs and Advocacy.

Effort to depose Rabbi Riskin are revenge against his positions and halachic decisions.

Appointing Gold, a strong right-winger, is a clear message to the Obama administration that Israel’s fed up with its illusions.

The Chief Rabbinate will invite Rabbi Riskin for a hearing on whether to extend his term, ostensibly because of his age but possibly because of his views on conversion.

Hareidi Jews dance as they celebrates the end of Jewish holiday of Shavuot at the Kotel in Jerusalem’s Old City on Sunday night (and that was after just 2 days, imagine how they danced in Galus after three!).

The terrorist organization also copied the Israeli phrase that Jerusalem always will be “undivided.”

Two cops who ordered a pizza vomited instead of getting high.

The terrorist organization’s “exposé” to a friendly Lebanese newspaper also is justification for the IDF to bomb human shields.

“You shall not take a bribe, for bribery blinds the eyes of the wise and perverts just words.” Deuteronomy 16:19

Actress and comedienne Meara Stiller died on Saturday at age 85.

Hezbollah terror chief Hassan Nasrallah is getting very scared of Islamic State’s advances.

More Articles from Anav Silverman, Tazpit News Agency
Volunteers with Shomer Hachadash.

Eight years ago, an Israeli rancher from Moshav Zippori in the Lower Galilee region reached a breaking point. Thieves and marauders had been targeting Chaim Zilberman’s sprawling ranch; his land was burnt black and cattle fences cut down. On the verge of bankruptcy, the rancher told his family during a Friday Shabbat dinner one night […]

Birthright Israel participants in Israel.

The educational organization will bring 1,500 French Jews to Israel to learn about the Jewish state and immerse them in their Jewish heritage.

PM Netanyahu sent a letter of condolences to the Levinger family on the passing of the late leader Rabbi Moshe Levinger, who was known for his life work in establishing the modern Jewish community of Hebron and as one of the founder of the Gush Emunim settlement movement.

MyECheck has bought Israeli company, Seergate Ltd, which concentrates on electronic payment solutions, for $3 million.

When they return home, participants will serve as goodwill ambassadors building bridges between the United States and Israel.

The largest oil and gas conference in the world, known as the Offshore Technology Conference (OTC) was held this week and 14 Israeli companies were present.

“I had just got the role of my life, Shylock,” recalled Elias. “But following all the hostilities, the Zionist underground members came to the rehearsal and took me away.” 

Netanyahu said, repeating the mistakes made with North Korea, this time with Iran, is a great historic blunder.

Printed from: http://www.jewishpress.com/news/breaking-news/tevas-parkinson-drug-now-marketed-in-japan/2014/05/29/

Scan this QR code to visit this page online: